Skip to main content
. 2016 Apr 2;7(19):27889–27898. doi: 10.18632/oncotarget.8556

Table 3. Read-through transcripts identified by Sanger sequencing of PCR amplicons.

Read-through name1 First transcript (exon)2 Second transcript (exon)2 Maintained frame
ARF3-FKBP11 NM_001659 (4) NM_001143781 (2) No
NM_001659 (4) NM_001143781 (3) No
CD59-C11orf91 NM_203331 (4)* NM_001166692 (2)* No
ELAVL1-TIMM44 NM_001419 (4) NM_006351 (2) No
HARS2-ZMAT2 NM_012208 (13)§ NM_144723 (2) No
HSD17B11-HSD17B13 NM_016245 (6) NM_178135 (2) No
NAA60-CLUAP1 NM_001083601 (2) NM_015041 (2) No
NKX2-1-SFTA3 NM_001079668 (1) NM_001101341 (2)§ No
PACSIN2-ARFGAP3 NM_001184970 (10) NM_001142293 (2) No
PLEKHO2-ANKDD1A NM_001195059 (5) NM_182703 (4) Yes
NM_001195059 (5) NM_182703 (5) Yes
PPRC1-NOLC1 NM_015062 (13) NM_004741 (2) No
SNTB2-VPS4A NM_006750 (6) NM_013245 (2) Yes
SPECC1L-ADORA2A NM_015330 (14) NM_000675 (3) Yes
TSTD1-F11R NM_001113205 (1) NM_016946 (2) Yes
1

Gene1-Gene2 symbol.

2

Exons joined by the read-through event.

*

A portion of intragenic region is included in the read-through transcript.

§

Incomplete exon.